Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.

CNRGH

Curtit E. et al.
Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
Breast Cancer Res. (2017) Aug. 19(1):98.
doi: 10.1186/s13058-017-0888-4

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.

Partager :